AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Park Ha Biological Technology Co., Ltd. Ordinary Shares
Video analysis: BYAH
All videosNo video analysis for this stock yet. Request one from our team.
News: BYAH
BYAH DEADLINE: Levi & Korsinsky Reminds Park Ha Biological Technology Co., Ltd. Investors of Upcoming Securities Class Action Deadline
Notice to Pension Funds, Asset Managers, and Fiduciaries: BYAH's July 8, 2025 single-session collapse erased more than $1 billion in market capitalization, and the lawsuit contends the Company's sub-5% public float structure left institutional holders exposed to alleged manipulation that was never disclosed. Notice to Pension Funds, Asset Managers, and Fiduciaries: BYAH's July 8, 2025 single-session collapse erased more than $1 billion in market capitalization, and the lawsuit contends the Company's sub-5% public float structure left institutional holders exposed to alleged manipulation that was never disclosed.
PARK HA DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Park Ha Biological Technology Co., Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - PHH, BYAH
NEW YORK, Sept. 12, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH) between December 27, 2024 and July 8, 2025, inclusive (the “Class Period”), of the important September 28, 2026 lead plaintiff deadline.
Robbins LLP Reminds Investors of the Securities Fraud Class Action Filed Against Park Ha Biological Technology Co, Ltd. After a 93% Decline in the Company's Stock
SAN DIEGO, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise acquired Park Ha Biological Technology Co., Ltd.
PHH, BYAH Deadline: PHH, BYAH Investors with Losses in Excess of $100K Have Opportunity to Lead Park Ha Biological Technology Co., Ltd. Securities Lawsuit
NEW YORK, Sept. 10, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Park Ha Biological Technology Co., Ltd.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Park Ha Biological Technology Co., Ltd. of Class Action Lawsuit and Upcoming Deadlines - BYAH
NEW YORK, Sept. 10, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Park Ha Biological Technology Co., Ltd.
BYAH Shareholder Alert: Park Ha Biological Technology Co., Ltd. Securities Class Action Lawsuit - Investors With Losses May Contact SueWallSt
BYAH reported just 39 franchisees and $551,970 in franchise fee revenue, yet the lawsuit contends BYAH carried a $1 billion market capitalization before shares collapsed 93% in a single session. NEW YORK, Sept.
PHH, BYAH DEADLINE ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Park Ha Biological Technology Co., Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - PHH, BYAH
New York, New York--(Newsfile Corp. - September 9, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) (NASDAQ: BYAH) between December 27, 2024 and July 8, 2025, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff deadline.
PHH, BYAH DEADLINE NOTICE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Park Ha Biological Technology Co., Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - PHH, BYAH
NEW YORK, Sept. 10, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH) between December 27, 2024 and July 8, 2025, inclusive (the “Class Period”), of the important September 28, 2026 lead plaintiff deadline.
Similar companies
-
Perfect Moment Ltd. Common Stock
PMNT
·
Other OTC
Compare
-
Creative Global Technology Holdings Limited Ordinary Shares
CGTL
·
NASDAQ
Compare
-
MEDIROM Healthcare Technologies Inc.
MRM
·
NASDAQ
Compare
-
DSS, Inc.
DSS
·
New York Stock Exchange Arca
Compare
-
U Power Limited
UCAR
·
NASDAQ
Compare
-
Autozi Internet Technology (Global) Ltd.
AZI
·
NASDAQ
Compare